• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

复制还是不复制:通过翻译控制实现溶瘤病毒在癌细胞中的选择性复制。

To replicate or not to replicate: achieving selective oncolytic virus replication in cancer cells through translational control.

作者信息

Mohr Ian

机构信息

Department of Microbiology, New York University School of Medicine, NY 10016, USA.

出版信息

Oncogene. 2005 Nov 21;24(52):7697-709. doi: 10.1038/sj.onc.1209053.

DOI:10.1038/sj.onc.1209053
PMID:16299530
Abstract

To ensure that their mRNAs are translated and that the viral proteins necessary for assembling the next generation of infectious progeny are produced, viruses must effectively seize control of the translational machinery within their host cells. In many cases, the ability to productively engage host translational components can determine if a given cell type can support viral replication, illustrating the critical importance of this task in the viral life cycle. Failure to interface properly with the host translational apparatus can compromise the productive growth cycle, resulting in an abortive infection and radically restricting viral replication. Not only have viruses become facile at commandeering this machinery, they are also particularly adept at manipulating cellular translation control pathways for their own ends. In this review, the mechanisms by which numerous viruses manipulate host translational control circuits are discussed. Furthermore, particular attention is devoted to understanding how interfering with the ability of a virus to properly regulate translation in its host can be exploited to generate oncolytic strains that selectively replicate in cancer cells.

摘要

为确保其mRNA能够被翻译并产生组装下一代感染性子代病毒所需的病毒蛋白,病毒必须有效地掌控其宿主细胞内的翻译机制。在许多情况下,有效利用宿主翻译组件的能力可决定特定细胞类型是否能够支持病毒复制,这表明此项任务在病毒生命周期中至关重要。若无法与宿主翻译装置正确对接,可能会损害生产性生长周期,导致流产感染并从根本上限制病毒复制。病毒不仅善于征用这种机制,还特别擅长为自身目的操纵细胞翻译控制途径。在本综述中,将讨论多种病毒操纵宿主翻译控制回路的机制。此外,还将特别关注如何利用干扰病毒在其宿主中正确调节翻译的能力来产生在癌细胞中选择性复制的溶瘤毒株。

相似文献

1
To replicate or not to replicate: achieving selective oncolytic virus replication in cancer cells through translational control.复制还是不复制:通过翻译控制实现溶瘤病毒在癌细胞中的选择性复制。
Oncogene. 2005 Nov 21;24(52):7697-709. doi: 10.1038/sj.onc.1209053.
2
VSV-tumor selective replication and protein translation.水泡性口炎病毒-肿瘤选择性复制与蛋白质翻译
Oncogene. 2005 Nov 21;24(52):7710-9. doi: 10.1038/sj.onc.1209042.
3
Phosphorylation and dephosphorylation events that regulate viral mRNA translation.调节病毒mRNA翻译的磷酸化和去磷酸化事件。
Virus Res. 2006 Jul;119(1):89-99. doi: 10.1016/j.virusres.2005.10.009. Epub 2005 Nov 21.
4
Future prospects for oncolytic therapy.溶瘤治疗的未来前景。
Oncogene. 2005 Nov 21;24(52):7817-9. doi: 10.1038/sj.onc.1209064.
5
The potential impact of hypoxia on the success of oncolytic virotherapy.缺氧对溶瘤病毒疗法成功与否的潜在影响。
Curr Opin Mol Ther. 2005 Aug;7(4):353-8.
6
Viruses - seeking and destroying the tumor program.病毒——寻找并摧毁肿瘤程序。
Oncogene. 2005 Nov 21;24(52):7640-55. doi: 10.1038/sj.onc.1209047.
7
What happens inside lentivirus or influenza virus infected cells: insights into regulation of cellular and viral protein synthesis.慢病毒或流感病毒感染细胞内发生了什么:对细胞和病毒蛋白质合成调控的见解
Methods. 1997 Apr;11(4):383-401. doi: 10.1006/meth.1996.0436.
8
Unshackling the links between reovirus oncolysis, Ras signaling, translational control and cancer.解除呼肠孤病毒溶瘤、Ras信号传导、翻译控制与癌症之间的联系。
Oncogene. 2005 Nov 21;24(52):7720-8. doi: 10.1038/sj.onc.1209041.
9
Virus-associated RNA I-deleted adenovirus, a potential oncolytic agent targeting EBV-associated tumors.病毒相关RNA I缺失型腺病毒,一种靶向EB病毒相关肿瘤的潜在溶瘤剂。
Cancer Res. 2005 Feb 15;65(4):1523-31. doi: 10.1158/0008-5472.CAN-04-3113.
10
Advances in oncolytic viral therapy.溶瘤病毒疗法的进展
Curr Opin Investig Drugs. 2006 Jun;7(6):549-59.

引用本文的文献

1
Oncolytic herpes simplex virus infects myeloma cells and .溶瘤单纯疱疹病毒感染骨髓瘤细胞并且…… (原文不完整)
Mol Ther Oncolytics. 2021 Feb 18;20:519-531. doi: 10.1016/j.omto.2021.02.009. eCollection 2021 Mar 26.
2
Oncolytic Virotherapy and Microenvironment in Multiple Myeloma.溶瘤病毒治疗与多发性骨髓瘤的微环境。
Int J Mol Sci. 2021 Feb 24;22(5):2259. doi: 10.3390/ijms22052259.
3
Targeting Poxvirus Decapping Enzymes and mRNA Decay to Generate an Effective Oncolytic Virus.靶向痘病毒脱帽酶和mRNA衰变以产生有效的溶瘤病毒。
Mol Ther Oncolytics. 2018 Jan 31;8:71-81. doi: 10.1016/j.omto.2018.01.001. eCollection 2018 Mar 30.
4
Effect of respiratory syncytial virus on the growth of hepatocellular carcinoma cell-lines.呼吸道合胞病毒对肝癌细胞系生长的影响。
BMB Rep. 2015 Oct;48(10):565-70. doi: 10.5483/bmbrep.2015.48.10.268.
5
Combinatorial strategies for oncolytic herpes simplex virus therapy of brain tumors.用于脑肿瘤溶瘤性单纯疱疹病毒治疗的联合策略
CNS Oncol. 2013 Mar;2(2):129-42. doi: 10.2217/cns.12.42.
6
Update on emerging antivirals for the management of herpes simplex virus infections: a patenting perspective.用于单纯疱疹病毒感染管理的新型抗病毒药物的最新进展:专利视角
Recent Pat Antiinfect Drug Discov. 2013 Apr;8(1):55-67. doi: 10.2174/1574891x11308010011.
7
Tinkering with translation: protein synthesis in virus-infected cells.修修补补的翻译:病毒感染细胞中的蛋白质合成。
Cold Spring Harb Perspect Biol. 2013 Jan 1;5(1):a012351. doi: 10.1101/cshperspect.a012351.
8
Viral subversion of the host protein synthesis machinery.病毒对宿主蛋白合成机制的颠覆。
Nat Rev Microbiol. 2011 Oct 17;9(12):860-75. doi: 10.1038/nrmicro2655.
9
Development of a regulatable oncolytic herpes simplex virus type 1 recombinant virus for tumor therapy.开发一种可调节的溶瘤单纯疱疹病毒 1 型重组病毒用于肿瘤治疗。
J Virol. 2010 Aug;84(16):8163-71. doi: 10.1128/JVI.00059-10. Epub 2010 Jun 2.
10
Oncolytic herpes simplex virus vectors and chemotherapy: are combinatorial strategies more effective for cancer?溶瘤单纯疱疹病毒载体与化疗:联合策略对癌症更有效吗?
Future Oncol. 2010 Apr;6(4):619-34. doi: 10.2217/fon.10.18.